News and Trends 28 Sep 2017 Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus …this first cohort, the rectal biopsies did not yield enough HIV DNA to make an assessment of the viral reservoir. For the ongoing second cohort, we have made changes to… September 28, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2017 Results are in from the First Human Trial of an Universal Cancer Vaccine …already established. The others, however, did not respond. To create the vaccines, the researchers sequence the patient’s tumor DNA and identify tumor mutations by comparing it to the DNA of… July 5, 2017 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 13 Mar 2018 The Most Important Battle in Gene Editing: CRISPR versus TALEN …its comparative simplicity and versatility in cleaving DNA. “Today, we think CRISPR is very interesting because it’s a very easy-to-use technology,” says Sourdive. “It’s very easy to use for academics… March 13, 2018 - 6 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
News and Trends 20 Oct 2022 The role of long-read sequencing in validating CRISPR outcomes …edits. Researchers have long struggled with more genomic changes than expected taking place during experiments – including deletions of stretches of DNA. And when making changes to DNA, specificity is… October 20, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 18 Aug 2025 mRNA vaccine funding cuts: the impact on U.S. healthcare and biotech …of recombinant DNA technologies,” said Kagan. He explained that while DNA technology led to the creation of numerous health innovations that drive society today, mRNA has similar potential, as it… August 18, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Nov 2025 Twice the punch: The emergence of dual-payload antibody and peptide drug conjugates …inhibition of a key resistance mechanism in the DNA Damage Repair (DDR) pathway.” This combination approach is designed to allow the potent anticancer drug to work by creating breaks in… November 18, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 20 Oct 2022 C4XD and HitGen to collaborate on inflammation hit identification project Drug discovery company C4X Discovery Holdings plc and HitGen Inc., which develops DNA-encoded library (DEL) technology, are to collaborate on identifying novel, small molecule hits against an inflammatory target for… October 20, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Nov 2022 The five hottest biotech startup companies in Brazil …genetic traits associated with disease in these populations. The firm aims to recruit over 200,000 participants to donate clinical and DNA samples. To finance its business and research, Gen-t recently… November 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 6 Jun 2022 Releasing the microbiome’s potential to restore European soils …species through DNA analysis,” Bonk explained. “The ‘fitness’ level of bacteria and their actual activity and metabolism rate are crucial to us. To address the two, we use statistical methods… June 6, 2022 - 9 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2024 8 biotech companies advancing new treatments for breast cancer in 2024 …cancer gene (BRCA) gene mutations. These mutations impair the ability of cancer cells to repair their DNA, and olaparib takes advantage of this weakness by further blocking DNA repair mechanisms. … November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 17 Feb 2023 Positive results for INOVIO recurrent respiratory papillomatosis trial …broader strategic vision of delivering on the potential of DNA medicines for patients.” About RRP RRP is a debilitating and rare disease caused primarily by HPV 6 and/or HPV 11…. February 17, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2025 Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology …into small pieces with a preference for double-stranded DNA. This leads to cell killing and final cell depletion of the cells expressing the targeted RNA Biomarker,” explained the co-founder and… February 4, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email